Abstract
Phagocytosis of opsonized particles by neutrophils and monocytes plays a central role in host defense mechanisms against foreign pathogens. This process depends on the interaction between C3bi, a degradation product derived from activation of the complement system, and the αMβ2 (CD11b/CD18, Mac-1) receptor, the major integrin on neutrophils. Previous studies had established a central role for the I domain, a stretch of ∼200 amino acids within the αM subunit in the binding of C3bi, as well as many other αMβ2 ligands. The present study was undertaken to establish the molecular basis of C3bi recognition by αMβ2. The strategy employed the use of a series of mutant receptors in which short segments of the I domain of αM were switched to the corresponding segments of αL, which is structurally very similar but does not bind C3bi. We report three major findings: (1) The C3bi binding pocket is composed of three regions, P147−R152, P201−K217, and K245−R261 of αM, which surround the cation binding site within the MIDAS motif of the I domain. (2) Within the latter segment, K245 plays a critical role in mediating C3bi binding to αMβ2. Mutation of K245 to Ala significantly reduced C3bi binding but had no effect on binding of another αMβ2 I domain ligand, NIF. (3) Blocking of C3bi binding to αMβ2 by monoclonal antibodies is achieved through two different mechanisms: direct competition for the ligand binding site or induction of conformational changes. Overall, these studies support the hypothesis that many of the ligands of αMβ2 bind to overlapping but not identical sites within the I domain. Although the same short structural segments within the I domain may be involved in binding, different amino acids within these segments may contact different ligands.

This publication has 15 references indexed in Scilit: